Filing Details

Accession Number:
0001437749-21-023912
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-10-19 16:56:06
Reporting Period:
2021-10-19
Accepted Time:
2021-10-19 16:56:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
946486 Windtree Therapeutics Inc WINT Biological Products, (No Disgnostic Substances) (2836) 943171943
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1573160 James Huang C/o Windtree Therapeutics, Inc.
2600 Kelly Road, Suite 100
Warrington PA 18976
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-10-19 50,000 $1.90 291,281 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,336,853 Indirect Via Panacea Venture Healthcare Fund I L.P.
Footnotes
  1. The shares were purchased in multiple trades at prices ranging from $1.84 to $1.93. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. The Reporting Person is a Director of Panacea Venture Healthcare Fund GP I L.P. The Reporting Person disclaims beneficial ownership of the shares held by Panacea Venture Healthcare Fund I L.P., except to the extent of his pecuniary interest therein.